ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain.

M F Jarvis; J L Wessale; C Z Zhu; J J Lynch; B D Dayton; S V Calzadilla; R J Padley; T J Opgenorth; E A Kowaluk

doi:10.1016/s0014-2999(99)00865-1

ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain.

Identifier:nobleid.org/w1/20260515/707EB3DC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/707EB3DC.svg?ark=w1%2F20260515%2F707EB3DC)](https://nobleid.org/work/w1/20260515/707EB3DC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain.

Identifier:nobleid.org/w1/20260515/707EB3DC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/707EB3DC.svg?ark=w1%2F20260515%2F707EB3DC)](https://nobleid.org/work/w1/20260515/707EB3DC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work